Parkinsonism & Related Disorders
Volume 11, Issue 1 , Pages 69-72 , January 2005

Parkinsonism associated with neurocysticercosis

Received 12 March 2004 ,Revised 12 July 2004 ,Accepted 15 July 2004.

References 

  1. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol. 1992;32(Suppl S125–127):
  2. Cardoso F. Infectious and transmissible movement disorders. In:  Jankovic J,  Tolosa E editor. Parkinson's disease and movement disorders. Baltimore, MD: Williams and Wilkins; 1998;p. 945–965
  3. Riley DE. Secondary parkinsonism. In:  Jankovic J,  Tolosa E editor. Parkinson's disease and movement disorders. Baltimore, MD: Williams and Wilkins; 1998;p. 317–339
  4. Keane JR. Tremor as the result of shunt obstruction: four patients with cysticercosis and secondary parkinsonism: report of four cases. Neurosurgery. 1995;37(3):520–522
  5. Verma A, Berger JR, Bowen BC, Sanchez-Ramos J. Reversible parkinsonian syndrome complicating cysticercus midbrain encephalitis. Mov Disord. 1995;10(2):215–219
  6. Cameron ML, Durack DT. Helminthic infections. In:  Scheid WM,  Whitley RJ,  Durack DT editor. Infections of the central nervous system. Philadelphia, PA: Lippincott-Raven; 1997;p. 845–856
  7. Takayanagui OM, Jardim E. Clinical aspects of neurocysticercosis: analysis of 500 cases. Arq Neuropsiquiatr. 1983;41(1):50–63
  8. Agapejev S, Yela DA, Gomes AE. Chronic brain edema in neurocysticercosis. Arq Neuropsiquiatr. 1998;56(3B):569–576
  9. Carpio A, Escobar A, Hauser WA. Cysticercosis and epilepsy: a critical review. Epilepsia. 1998;39(10):1025–1040
  10. Forlenza OV, Filho AH, Nobrega JP, dos Ramos Machado L, de Barros NG, de Camargo CH, et al. Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil. J Neurol Neurosurg Psychiatry. 1997;62(6):612–616
  11. Cantu C, Barinagarrementeria F. Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch NeuroI. 1996;53(3):233–239
  12. Sawhney IM, Singh G, Lekhra OP, Mathuriya SN, Parihar PS, Prabhakar S. Uncommon presentation of neurocysticercosis. J Neurol Sci. 1998;154(1):94–100
  13. Bhigjee AI, Kemp T, Cosnett JE. Cerebral cysticercosis presenting with hemichorea. J Neurol Neurosurg Psychiatry. 1987;50(11):1561–1562
  14. Revuelta-Gutierrez R, Soto-Hernandez JL, Suategui-Ronan R, Ramos-Peek J. Transient hemifacial spasm associated with subarachnoid brainstem cysticercosis. Neurosurg Rev. 1998;21(2-3):167–170
  15. Agapejev S. Epidemiology of neurocysticercosis in Brazil. Rev Inst Med Trop Sao Paulo. 1996;38(3):207–216
  16. Cosentino C, Velez M, Torres L, Garcia HH. Cysticercosis lesions in basal ganglia are common but clinically silent. Clin Neurol Neurosurg. 2002;104(1):57–60
  17. Hirano F, Makino I, Kimura K, Narita S. A case of parkinsonism due to pontine and extrapontine myelinolysis. Rinsho Shinkeigaku. 1992;32(9):1006–1012
  18. Shibata N, Moroo I, Hayashi M. Parkinsonism associated with cerebrotendinous xanthomatosis. Rinsho Shinkeigaku. 1990;30(9):978–984
  19. Oliver L. Parkinsonism due to midbrain compression. Lancet. 1959;2:817–819
  20. Curran T, Lang AE. Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses. Mov Disord. 1994;9(5):508–520
  21. de la Fuente-Fernandez R, Stoessl AJ. The biochemical bases of the placebo effect. Sci Eng Ethics. 2004;10(1):143–150
  22. de la Fuente-Fernandez R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science. 2001;293(5532):1164–1166
  23. Goetz CG, Leurgans S, Raman R, Parkinson study group . Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease. Mov Disord. 2002;17(2):283–288
  24. Garcia HH, Evans CAW, Nash TE, Takayanagui OM, White AC, Botero D, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev. 2002;15(4):747–756
  25. Agapejev S, da Silva MD, Ueda AK. Severe forms of neurocysticercosis: treatment with albendazole. Arq Neuropsiquiatr. 1996;54(1):82–93
  26. Rosenfeld EA, Byrd SE, Shulman ST. Neurocysticercosis among children in Chicago. Clin Infect Dis. 1996;23(2):262–268
  27. Case records of the Massachusetts General Hospital . Weekly clinicopathological exercises. Case 24-2000. A 23-year-old man with seizures and a lesion in the left temporal lobe. N Engl J Med. 2000;343:420–427

PII: S1353-8020(04)00125-7

doi: 10.1016/j.parkreldis.2004.07.009

Parkinsonism & Related Disorders
Volume 11, Issue 1 , Pages 69-72 , January 2005

Article Tools

* Image Usage & Resolution